SNGX
SOLIGENIX, INC.
NASDAQ · Healthcare · Biotechnology · US
$0.38
+1.57%Next report
Analyst consensus
- Next report date
- Nov 6, 2026
- EPS estimate
- -$0.12
- Revenue estimate
- —
Latest reported
- Last report date
- Aug 7, 2026
- EPS actual
- -$0.12
- EPS estimate
- -$0.15
- Revenue actual
- —
- Revenue estimate
- —
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 9
- EPS misses (12Q)
- 3
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- +8.3%
- Revenue beats (12Q)
- 3
No earnings call summaries available
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Aug 7, 2026 | -$0.15 | -$0.12 | Beat 22.58% | — |
| May 8, 2026 | -$0.30 | -$0.28 | Beat 6.67% | — |
| Nov 7, 2025 | -$0.63 | -$0.58 | Beat 7.94% | — |
| Aug 14, 2025 | -$0.79 | -$0.82 | Miss -3.80% | — |
| May 9, 2025 | -$0.67 | -$1.06 | Miss -58.21% | — |
| Mar 21, 2025 | -$0.95 | -$1.14 | Miss -20.00% | $6.4K |
| Nov 8, 2024 | -$1.09 | -$0.78 | Beat 28.44% | — |
| Aug 9, 2024 | -$2.11 | -$1.31 | Beat 37.91% | — |
| May 10, 2024 | -$3.20 | -$2.88 | Beat 10.00% | $117.0K |
| Mar 15, 2024 | -$3.04 | -$2.56 | Beat 15.79% | $244.8K |
| Aug 21, 2023 | -$7.84 | -$2.72 | Beat 65.31% | $206.9K |
| May 15, 2023 | -$20 | -$5.76 | Beat 71.20% | $257.2K |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 6, 2026